BiotechTube

Pimecrolimus 1% cream

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Oral Lichen Planus

Conditions

Oral Lichen Planus

Trial Timeline

Aug 1, 2005 → Feb 1, 2009

NCT ID
NCT00297037

About Pimecrolimus 1% cream

Pimecrolimus 1% cream is a phase 2 stage product being developed by Novartis for Oral Lichen Planus. The current trial status is completed. This product is registered under clinical trial identifier NCT00297037. Target conditions include Oral Lichen Planus.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT00208026Phase 1/2Completed
NCT00297037Phase 2Completed

Competing Products

20 competing products in Oral Lichen Planus

See all competitors
ProductCompanyStageHype Score
AL001 + Placebo + Open label - AL001AlectorPhase 3
69
AL001AlectorPhase 2
44
AG013OragenicsPhase 2
44
LP-10 (Liposomal Tacrolimus)Lipella PharmaceuticalsPhase 2
44
Micafungin + FluconazoleAstellas PharmaPhase 3
77
micafungin + caspofunginAstellas PharmaPhase 3
77
Erlotinib + PlaceboAstellas PharmaPhase 3
77
AmifostineSun PharmaceuticalApproved
85
exenatide + Other antidiabetic therapiesEli LillyPre-clinical
23
Teriparatide 20 mcgEli LillyPhase 3
77
LY3884963 + Methylprednisolone + Optional Sirolimus + Optional PrednisoneEli LillyPhase 1/2
41
Baricitinib 4 milligram Oral TabletEli LillyPhase 2
52
tramadol hydrochloride + acetaminophenJohnson & JohnsonApproved
85
Essential oils + 0.2% chlorhexidine + Sterile waterJohnson & JohnsonApproved
85
galantamine hydrobromideJohnson & JohnsonPhase 2
52
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
77
Camrelizumab + Camrelizumanb plus TPFJiangsu Hengrui MedicinePhase 2
52
Camrelizumab plus TP + TPJiangsu Hengrui MedicinePhase 3
77
AZD1981 + Neovletta 21/28 + Placebo AZD1981AstraZenecaPhase 1
33
DurvalumabAstraZenecaPhase 1/2
41

Other Products from Novartis

LCZ696Approved
85
zoledronic acidApproved
85
NateglinideApproved
85
TenofovirApproved
85
FTY720Approved
85